Tel Aviv, Israel

Shlomo Wientroub


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shlomo Wientroub: Innovator in Osteogenic Research

Introduction

Shlomo Wientroub is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of osteogenic research, particularly through his innovative patents. With a total of 2 patents, Wientroub's work focuses on the development of monoclonal antibodies and methods for regulating bone-forming cells.

Latest Patents

Wientroub's latest patents include groundbreaking advancements in the understanding of osteoblast and fibroblast antigens. His first patent describes monoclonal antibodies (MAb) that exhibit binding specificity to an antigen expressed on osteogenic and fibroblastic cells (OFA). These antibodies are capable of binding to osteogenic and fibroblastic cells at a significantly higher extent compared to their binding to skin fibroblasts and stromal adipocytes. Additionally, he has identified a novel osteogenic and fibroblastic antigen (OFA) that is expressed at a higher level on these cells than in skin fibroblasts and stromal adipocytes, with a molecular weight of approximately 80 kD as determined by western blotting or immunoprecipitation. This discovery has potential applications in the diagnosis and treatment of various bone-related conditions. His second patent outlines a method for regulating bone-forming cells, which involves collecting regulation factors from bone stromal cells, including marrow adipocytes, and treating bone-forming cells with these factors to modify their behavior.

Career Highlights

Throughout his career, Wientroub has worked with esteemed institutions, including Ramot University Authority for Applied Research and Industrial and Ramot University Authority. His research has significantly advanced the understanding of bone biology and has implications for therapeutic strategies in bone-related diseases.

Collaborations

Wientroub has collaborated with various professionals in his field, including Dafna Benayahu, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Shlomo Wientroub's contributions to osteogenic research through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in the diagnosis and treatment of bone-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…